Key Stats
- Current Price: $99 (May 8, 2026)
- FY2026 Revenue: $4.71B, +7% YoY
- FY2026 Non-GAAP EPS: $1.64 per diluted share
- Q4 FY2026 Revenue: $1.31B, +35% YoY, +11% sequentially
- Q4 FY2026 Non-GAAP EPS: $0.57
- Q1 FY2027 Revenue Guidance: +11% sequentially (midpoint), +35% YoY at midpoint
- Q1 FY2027 Non-GAAP EPS Guidance: $0.67 to $0.71
- TIKR Model Price Target: $195
- Implied Upside: ~96% over 5 years (15% annualized)
Microchip Technology Stock Posts Best Revenue Quarter in Years as Recovery Broadens
Microchip Technology stock (MCHP) delivered $1.31B in Q4 FY2026 net sales, up 35% year-over-year and above the high end of guidance, with non-GAAP EPS of $0.57 coming in $0.07 above the midpoint of the company’s own forecast.
The aerospace and defense sector was the strongest performer in the quarter, according to CEO Steve Sanghi on the Q4 FY2026 earnings call, with FPGA products leading from a business unit perspective.
Non-GAAP gross margin reached 61.6% in Q4, up from 52% at the bottom of the cycle in March 2025, as Microchip continues executing against its stated long-term target of 65%.
Non-GAAP operating income reached 30.6% of sales in Q4, more than doubling from the 14% operating margin posted at the cycle trough.
Inventory days fell to 185 at March 31, 2026, down from 266 days at the December 2024 peak, with distribution inventory now below normal levels and large restocking orders beginning to materialize.
The book-to-bill ratio for Q4 was well above 1, and April 2026 was the largest booking month in nearly four years, according to Sanghi.
For Q1 FY2027, Microchip guided net sales up 11% sequentially (plus or minus 1%), implying growth of approximately 35% year-over-year at the midpoint, with non-GAAP EPS of $0.67 to $0.71.
Supply constraints are emerging across the business: lead times are extending broadly, substrate availability is tight, and foundry capacity across roughly 70% to 80% of process nodes is described as very tight by management.
Within the Data Center Solutions unit, Microchip secured six PCIe Gen 6 switch design wins prior to production volume release, and entered the PCIe retimer market this quarter with a major OEM design win already in hand, according to VP Brian McCarson on the earnings call.
The company’s nine-point recovery plan is substantially complete, with inventory reduction and margin improvement the remaining active workstreams, and the Tempe fab sale still pending with multiple interested parties.
Microchip Technology Stock: What the Income Statement Shows
The income statement traces a clear recovery arc from a multi-quarter trough to a return to operating leverage.

Revenue bottomed at $970M in Q1 FY2026 (March 2025 quarter) after falling from $1.24B in June 2024, a decline driven by the post-COVID inventory correction across distributors and direct customers.
The rebound since then has been steady: revenue rose to $1.08B in Q2 FY2026, $1.14B in Q3, $1.19B in Q4, and $1.31B in Q1 FY2026 (March 2026 quarter), with the latest reading up 35% year-over-year.
Gross margin compressed from 59% in June 2024 all the way to 52% at the March 2025 trough, then recovered to 54% in June 2025, 56% in September 2025, 60% in December 2025, and 61% in the most recent quarter.
Operating margin followed the same trajectory: from 18% in June 2024 down to -3% at the March 2025 trough, recovering to 5%, 8%, 13%, and 17% in the four subsequent quarters.
Operating income swung from a $30M loss in March 2025 to $220M in the March 2026 quarter, a 923% year-over-year gain, reflecting both the revenue recovery and meaningful progress on operating expense discipline.
CFO Eric Bjornholt attributed $46.6M of underutilization charges as the primary barrier between current gross margins and the 65% long-term target, noting that removing those charges would put Microchip essentially at the target today.
What Does the Valuation Model Say?
TIKR’s valuation model sets a price target of $194.62 for Microchip Technology stock, representing approximately 96% total upside from the current price of $99.09, or roughly 15% annualized over 4.9 years.
The mid-case assumptions driving that target are a revenue CAGR of approximately 10% and a net income margin of approximately 30%.
The Q4 result and Q1 FY2027 guidance strengthen the model’s foundation, with the margin progression from 14% operating income at the trough to 31% in Q4 indicating that Microchip Technology stock’s earnings power is rebuilding faster than the cycle suggested it would.
The investment case is stronger after this report than before it, though the implied upside still depends on sustained execution through a supply-constrained environment.

The debate for Microchip Technology stock centers on whether the $46.6M underutilization charge that separates the current 61% gross margin from the 65% long-term target compresses fast enough as factory ramps accelerate through FY2027.
The six PCIe Gen 6 design wins secured before production ramp and distributor channel inventory sitting below historical norms at 26 days represent the clearest near-term catalysts for the revenue trajectory management guided.
Substrate tightness already producing delinquency across data center, connectivity, and automotive, combined with inventory still at 185 days against a 130 to 150-day long-term target, means the margin recovery has less room for error than the headline numbers suggest.
Should You Invest in Microchip Technology Incorporated?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Microchip Technology stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Microchip Technology Incorporated alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze MCHP stock on TIKR for Free →


